Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
about
Performance of dye-affinity beads for aluminium removal in magnetically stabilized fluidized bedCholinotoxic effects of aluminum in rat brainWater content of aluminum, dialysis dementia, and osteomalacia.The elements of life and medicinesPotential human health effects of acid rain: report of a workshopAluminum and chronic renal failure: sources, absorption, transport, and toxicity.Aluminum and Alzheimer's disease: perspectives for a cytoskeletal mechanism.Pharmacotherapy of end-stage renal disease.Evidence of aluminium accumulation in aluminium welders.Aluminium bone disease in patients receiving plasma exchange with contaminated albuminThe management of intractable haematuria.Pharmacology, efficacy and safety of oral phosphate binders.Accumulation of aluminium in chronic renal failure due to administration of albumin replacement solutionsCompounds in development to combat hyperphosphataemia.Osteo-renal regulation of systemic phosphate metabolism.Beraprost sodium protects against chronic brain injury in aluminum-overload rats.Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysisHigh aluminium content of infant milk formulas.Magnesium biomaterials for orthopedic application: a review from a biological perspective.Iron-based phosphate binders--a new element in management of hyperphosphatemia.The use of chelating agents in the treatment of aluminum overload.Nanostructured Ti-Zr-Pd-Si-(Nb) bulk metallic composites: Novel biocompatible materials with superior mechanical strength and elastic recovery.Safety Assessment of Alumina and Aluminum Hydroxide as Used in Cosmetics.Neurobehavioral impairment and symptoms associated with aluminum remelting.Aluminum inhibits erythropoiesis in vitro.Aluminium accumulation and immunosuppressive effect in recipients of kidney transplants.Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate.Vitamin D and aluminum absorption.Aluminium perturbs oscillatory phosphoinositide-mediated calcium signalling in hormone-stimulated hepatocytesEffects of combined exposure to aluminium and ethanol on aluminium body burden and some neuronal, hepatic and haematopoietic biochemical variables in the rat.Preparation of magnetic dye affinity adsorbent and its use in the removal of aluminium ions.Molecular recognition-based detoxification of aluminum in human plasma.Impact of sevelamer hydrochloride and the K/DOQI guidelines.Lanthanum carbonate.Tannoid principles of Emblica officinalis renovate cognitive deficits and attenuate amyloid pathologies against aluminum chloride induced rat model of Alzheimer's disease.Effects of aluminum sulfate on delta-aminolevulinate dehydratase from kidney, brain, and liver of adult mice.Comparative aluminium mobilizing actions of several chelators in aluminium-loaded uraemic rats.Aluminum in the neonate related to parenteral nutrition.ICP-MS determination of serum aluminum in monkeys subcutaneously administered an alhydrogel-formulated drug candidate.The crystal structure and chemical state of aluminum-doped hydroxyapatite by experimental and first principles calculation studies.
P2860
Q24805803-B98F0343-CE50-450F-A5D2-0A03D50D585EQ28333138-2BE7476B-D9DB-466F-8F5D-7F354C1BDFA8Q28390919-F9C56390-001A-4B4A-A7B2-9A68D9A48893Q28649323-AA4C13ED-4444-4495-931F-110060855173Q28767719-8C343E2A-A65D-434B-869C-98DB5DBCB20BQ30459816-4D734FC3-887C-4EA9-A297-FD4CF1DD8F01Q30462285-2C5DE40B-568D-47C5-B4EA-CF3AB4D80E79Q33531889-10197802-70C6-43D3-BEE0-87FE32E28701Q33634624-A03750BC-BEB7-47FA-A12E-B97982CC951FQ34072250-77758A1C-7E53-4C71-A16D-845567A5FF80Q34105522-556A8BB7-C48C-4D23-8271-D5444C354E80Q34213752-78F3C97E-606B-4C3B-B15C-EE134EAF26DEQ34283287-C84F8DDF-849E-404A-BA30-D5D09F4E0960Q34481935-122715F0-87A6-45EB-BB27-8D77E06A3485Q35059741-6C524A0C-C8F1-4F01-8C4A-27E795C3569FQ35079198-E05F1FD0-B5A3-4824-AC1A-2EE6EE8AC5D7Q35351243-9B02E7C5-BE0E-44DE-80E5-388644DB347EQ35603271-D036C4DC-0905-45C2-A338-7841C425BD10Q38181438-9FADE6FA-FB1D-4CAD-A49D-AEDC69167BCEQ38295285-59D7DBD6-4AEA-4F3A-9869-6BC5C4EBA31AQ38775147-05A712B2-601F-4935-BDF2-2214595397ACQ38926218-A1D157CC-3608-4777-A5BE-7F80437AFD67Q39028072-92D6F654-3836-44E8-B4D5-88F89CFB4AF0Q40840360-38C987B9-EEA3-4312-B192-6F83B25E44E3Q41017344-C40AA609-B897-460B-9B4F-A816E163F62DQ42052940-759546E9-6391-401A-A2DB-E40977254C5EQ42260120-1ACA4D01-385B-4841-8BED-BF4E43D92E6FQ42691762-787B6B53-F4AF-4CB8-A079-2DCA0036DACFQ42794785-83783380-9A22-4B5A-B277-A9B917C2D9F3Q44216009-7B45CFBE-3CF8-41D5-9A95-EE88F194BDA9Q45712195-AF52A8BA-24E0-4464-B187-48A63D631B3AQ45972728-F101EDAF-B5FF-4605-BEA3-D20357E123BFQ46657632-968EDE2B-0291-47E8-82F7-3E06480485C7Q46921582-1CC08124-6FCB-497B-8B67-9D9541594577Q47424230-789EF6F4-EDFC-42C8-A0E4-531DEAAB9EF7Q48159016-EF2499A2-2D4D-4736-A2F7-490A7E73E13CQ48186024-56102593-46C2-4794-945F-CDDA08C647B9Q48200738-C508D83C-A847-41D1-8D14-2646AC2DFA0BQ49679453-44301E33-F471-4576-8661-1BEFC617C2E8Q53063821-01EF1C80-A9A0-435C-A6E7-646F2C9BEC03
P2860
Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh-hant
name
Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
@en
Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
@nl
type
label
Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
@en
Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
@nl
prefLabel
Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
@en
Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
@nl
P1433
P1476
Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
@en
P2093
P356
10.1016/S0140-6736(83)90014-4
P407
P577
1983-07-01T00:00:00Z